The Canadian Pediatric and Perinatal HIV/AIDS Research Group is a collection of clinicians and researchers that form the primary resource for pediatric HIV in Canada
A new CTN study investigates how exposure to HIV and antiretroviral drugs during pregnancy could have long-term effects for the millions of kids who were born to mothers living with HIV, but who did not acquire the virus themselves
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
While exclusive formula feeding remains the preferred recommendation for infants born to women living with HIV in high-income countries, a more nuanced approach that may include the option of breastfeeding under certain circumstances is emerging in many resource-rich countries.
The objective of the Canadian HIV Pregnancy Planning Guidelines is to provide clinical information and recommendations for health care providers to assist Canadians affected by HIV with their fertility, preconception, and pregnancy planning decisions.
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
Whey Protein Supplementation in HIV-Infected Children: A Pilot Study
Anemia Among HIV-infected Children Receiving Zidovudine: Identification of Markers of Erythropoietin Deficiency and Likelihood of Response to Exogenous Erythropoietin
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
Bone and renal outcomes in HIV-exposed uninfected infants with perinatal exposure to tenofovir
Preterm Birth in HIV+ Pregnancies This study investigated the effect of antiretroviral therapy (ART) on pregnant women and their infants using two experimental laboratory tests. The first test was for mitochondrial DNA (mtDNA) and examined the quantity and quality of mtDNA. The second test looked at the damage the drugs may do to the length…
Preterm Birth in HIV+ Pregnancies This cohort study is investigating the effect of antiretroviral therapy (ART) on pregnant women and their infants through the measurement of markers of placental health. The study is analyzing mitochondrial DNA (mtDNA) in the placenta and other markers in the mothers blood to estimate the health of the placental cells…
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.